An Overview of Experimental and Clinical Spinal Cord Findings in Alzheimer’s Disease

• Main Authors: Qing Xie, Wei-Jiang Zhao, Guan-Yong Ou, Wei-Kang Xue
• Format: Article
• Language: English
• Published: MDPI AG 2019-07-01
• Series: Brain Sciences
• Subjects: Alzheimer’s disease (AD); spinal cord; pathological changes; β-amyloid protein; tau protein; inflammation
• Online Access: https://www.mdpi.com/2076-3425/9/7/168

Alzheimer’s disease (AD) is a neurodegenerative disorder that occurs mainly in the elderly and presenile life stages. It is estimated that by the year 2050, 135 million people will be affected by AD worldwide, representing a huge burden to society. The pathological hallmarks of AD mainly include intracellular neurofibrillary tangles (NFTs) caused by hyperphosphorylation of tau protein, formation of extracellular amyloid plaques, and massive neural cell death in the affected nervous system. The pathogenesis of AD is very complicated, and recent scientific research on AD is mainly concentrated on the cortex and hippocampus. Although the spinal cord is a pivotal part of the central nervous system, there are a limited number of studies focusing on the spinal cord. As an extension of the brain, the spinal cord functions as the bridge between the brain and various parts of the body. However, pathological changes in the spinal cord in AD have not been comprehensively and systematically studied at present. We here review the existing progress on the pathological features of AD in the spinal cord.